Regeneron Pharmaceuticals and Calixar have entered a partnership, the value of which is undisclosed, focused on research into antibodies in various therapeutic fields. The collaboration gives Regeneron exclusive licensing rights to Calixar's native membrane protein stabilization technology.
Calixar partners with Regeneron on antibody research
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.